Search Results for keywords:"Philadelphia"

Found 2 results
Skip to main content

Search Results: keywords:"Philadelphia"

  • Type:Notice
    Citation:90 FR 9887
    Reading Time:about a minute or two

    Piramal Pharma Solutions has notified the Foreign-Trade Zones Board about proposed production activities at their facility in Philadelphia, within FTZ 35. They plan to produce bempedoic acid tablets and bempedoic oral suspension. The public is encouraged to submit comments on this proposal by March 31, 2025. More details are available on the Board's website, and interested parties can contact Kolade Osho for further information.

    Simple Explanation

    Piramal Pharma Solutions wants to make a new medicine in Philadelphia and they are letting people know about it, so folks can say what they think. People can send their thoughts online before the end of March to help decide if it's a good idea.

  • Type:Notice
    Citation:90 FR 13731
    Reading Time:less than a minute

    PCI Pharma Services submitted a notification on November 21, 2024, to the Foreign-Trade Zones (FTZ) Board about proposed production activities at their facilities in Croydon and Philadelphia, Pennsylvania. The notification followed FTZ Board regulations, and public comments were invited through a notice in the Federal Register on November 29, 2024. By March 21, 2025, the FTZ Board decided that no further review was needed, and authorized the production activity as per the FTZ Act and regulations.

    Simple Explanation

    PCI Pharma Services, a company in Pennsylvania, got permission to make medicines in special areas called Foreign-Trade Zones, which helps them do this more easily and cheaply. The permission was given after making sure everything was okay and letting people share their thoughts.